Ratings by Roth/MKM (Zegbeh Jallah)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/11/2022 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2022 | Ocugen, Inc. | OCGN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/23/2022 | Rezolute | RZLT | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2021 | Rezolute | RZLT | New Coverage | Buy (N/A) |
9.74 (2.60) |
-73.31% | Details | |
| 8/9/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2021 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Rapt Therapeutics | RAPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | X4 Pharmaceuticals | XFOR | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Ocugen, Inc. | OCGN | Downgrade | Neutral (Buy) |
9.31 (1.94) |
-79.16% | Details | |
| 5/18/2021 | Clearside Biomedical | CLSD | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2021 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
18.61 (38.62) |
107.52% | Details | |
| 4/16/2021 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2021 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Ocugen, Inc. | OCGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2021 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2021 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2021 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2020 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2020 | Ocugen, Inc. | OCGN | New Coverage | Buy (N/A) |
0.29 (9.31) |
3110.34% | Details | |
| 10/27/2020 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2020 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
1.04 (0.29) |
-72.12% | Details | |
| 9/9/2020 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2020 | Enanta Pharmaceuticals | ENTA | New Coverage | Buy (N/A) |
49.90 (12.48) |
-74.99% | Details | |
| 8/19/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Glycomimetics | GLYC | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2020 | Turning Point Therapeutics Inc. | TPTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2020 | Ideaya Biosciences | IDYA | New Coverage | Buy (N/A) |
4.85 (38.62) |
696.29% | Details | |
| 3/4/2020 | aTyr Pharma | LIFE | New Coverage | Buy (N/A) |
3.72 (1.60) |
-56.99% | Details | |
| 1/28/2020 | Applied Genetic Technologies Corp. | AGTC | New Coverage | Buy (N/A) |
7.40 (0.39) |
-94.73% | Details | |
| 12/18/2019 | X4 Pharmaceuticals | XFOR | New Coverage | Buy (N/A) |
11.00 (1.13) |
-89.73% | Details | |
| 11/14/2019 | Glycomimetics | GLYC | New Coverage | Buy (N/A) |
5.96 (1.71) |
-71.31% | Details | |
| 11/14/2019 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
26.55 (31.60) |
19.02% | Details | |
| 11/14/2019 | Turning Point Therapeutics Inc. | TPTX | New Coverage | Buy (N/A) |
47.74 (76.01) |
59.22% | Details | |
| 11/14/2019 | Harpoon Therapeutics | HARP | New Coverage | Buy (N/A) |
13.15 (23.01) |
74.98% | Details | |
| 9/6/2019 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2019 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
23.89 (10.49) |
-56.09% | Details |
